The related studies have shown that the disorders of the serotonin system, including abnormalities in the 5-HT1A receptor expression and the serotonin neurotransmitter level, lead to the development of neuropsychiatric diseases, such as major depression, anxiety, epilepsy and schizophrenia. Here, HTR1A is linked to schizophrenia.